M&A

News

Bausch + Lomb dips on rumour of failing takeover talks

Private equity group Blackstone is reported to be thinking of pulling out of a consortium to buy ophthalmology specialist Bausch + Lomb.

News

Novo’s $16.5bn Catalent deal cleared by EU Commission

EU says Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation Catalent does not pose antitrust issues.

News

Grifols slides as Brookfield pulls out of takeover talks

Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's shares

News

Roche buys off-the-shelf CAR-T player Poseida for $1bn

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid

News

Halozyme abandons its €2bn pursuit of Evotec

Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been unwilling to engage with negotiations

News

Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn

Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys

Bausch + Lomb dips on rumour of failing takeover talks

Novo’s $16.5bn Catalent deal cleared by EU Commission

Grifols slides as Brookfield pulls out of takeover talks

Roche buys off-the-shelf CAR-T player Poseida for $1bn

Halozyme abandons its €2bn pursuit of Evotec

Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn

On the future of AI in life sciences, with women at the helm

How to meet your physicians where they are online

M&A

Editor's Picks